207 related articles for article (PubMed ID: 6335599)
1. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.
Ekström B
Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599
[TBL] [Abstract][Full Text] [Related]
2. Trends in the development of beta-lactam antibiotics.
Neu HC
Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
[TBL] [Abstract][Full Text] [Related]
3. 5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases.
Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Ado M; Tsuyoshi T; Dos Santos O; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Weiss WJ; Shlaes DM; Mansour TS
Bioorg Med Chem; 2008 Feb; 16(4):1890-902. PubMed ID: 18061461
[TBL] [Abstract][Full Text] [Related]
4. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
5. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
Labia R; Morand A; Pitton JS; Philippin JL; Fournier P
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.
Sala A; Chiarino D; Napoletano M; Albini E; Carenzi A
Farmaco; 1991; 46(7-8):887-97. PubMed ID: 1793473
[TBL] [Abstract][Full Text] [Related]
8. The evolution of antibiotic production and public health problems.
Mansford KR; Slocombe B
Chemioterapia; 1987 Jun; 6(3):234-40. PubMed ID: 3496977
[TBL] [Abstract][Full Text] [Related]
9. Studies on monocyclic beta-lactam antibiotics. V. Synthesis and antibacterial activity of 3-[2-(2-aminothiazol-4-yl)-(Z)-2-(O-substituted oxyimino)-acetamido]-1-(1H-tetrazol-5-yl)-2-azetidinones having various functional groups at C-4 position of beta-lactam.
Yoshida C; Tanaka K; Hattori R; Fukuoka Y; Komatsu M; Kishimoto S; Saikawa I
J Antibiot (Tokyo); 1986 Feb; 39(2):215-29. PubMed ID: 3957788
[TBL] [Abstract][Full Text] [Related]
10. [Nontraditional beta-lactam antibiotics].
Vanderhaeghe H
Verh K Acad Geneeskd Belg; 1991; 53(1):39-58; discussion 58-9. PubMed ID: 2053420
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.
Decuyper L; Jukič M; Sosič I; Žula A; D'hooghe M; Gobec S
Med Res Rev; 2018 Mar; 38(2):426-503. PubMed ID: 28815732
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimicrobial properties of substituted 3-aminoxypropionyl and 3-aminoxy-(E)-2-methoxyiminopropionyl monobactams.
Balsamo A; Macchia B; Orlandini E; Rossello A; Macchia F; Broccali G; Fonio W
Farmaco; 1990 Jul; 45(7-8):879-88. PubMed ID: 2282121
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
14. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
[TBL] [Abstract][Full Text] [Related]
15. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
16. The impact of beta-lactamases on the development of novel antimicrobial agents.
Bush K
Curr Opin Investig Drugs; 2002 Sep; 3(9):1284-90. PubMed ID: 12498001
[TBL] [Abstract][Full Text] [Related]
17. Are all beta-lactams created equal?
Livermore DM
Scand J Infect Dis Suppl; 1996; 101():33-43. PubMed ID: 9060050
[TBL] [Abstract][Full Text] [Related]
18. Use of new beta-lactam antibiotics in intraabdominal surgery.
Kager L; Nord CE
Scand J Infect Dis Suppl; 1984; 42():143-50. PubMed ID: 6335598
[TBL] [Abstract][Full Text] [Related]
19. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Kumagai T; Petersen PJ; Weiss WJ; Lenoy E; Yang Y; Shlaes DM; Ryan JL; Mansour TS
Bioorg Med Chem; 2004 Nov; 12(22):5807-17. PubMed ID: 15498657
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.
Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Ado M; Tsuyoshi T; Dos Santos O; Gu Y; Sum FW; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Kumagai T; Weiss WJ; Shlaes DM; Knox JR; Mansour TS
J Med Chem; 2006 Jul; 49(15):4623-37. PubMed ID: 16854068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
